TFF Pharmaceuticals Inc (TFFP)
2.21
0.00 (0.00%)
USD |
NASDAQ |
May 28, 16:00
2.25
+0.04
(+1.81%)
After-Hours: 20:00
TFF Pharmaceuticals Cash from Operations (TTM): -14.82M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
March 31, 2024 | -14.82M |
December 31, 2023 | -16.04M |
September 30, 2023 | -19.53M |
June 30, 2023 | -23.91M |
March 31, 2023 | -24.46M |
December 31, 2022 | -27.34M |
September 30, 2022 | -30.52M |
June 30, 2022 | -30.34M |
March 31, 2022 | -31.21M |
Date | Value |
---|---|
December 31, 2021 | -29.56M |
September 30, 2021 | -24.91M |
June 30, 2021 | -21.97M |
March 31, 2021 | -19.85M |
December 31, 2020 | -16.62M |
September 30, 2020 | -14.69M |
June 30, 2020 | -13.51M |
March 31, 2020 | -11.45M |
December 31, 2019 | -11.22M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-31.21M
Minimum
Mar 2022
-11.22M
Maximum
Dec 2019
-21.22M
Average
-20.91M
Median
Cash from Operations (TTM) Benchmarks
Lifecore Biomedical Inc | -34.46M |
Jaguar Health Inc | -30.34M |
Genprex Inc | -23.10M |
Aquestive Therapeutics Inc | -25.58M |
NovaBay Pharmaceuticals Inc | -4.516M |